SCHEMBL4228486

SCHEMBL4228486

C=CCn1c2ccc(C(C)(C)C)cc2c2cc(C(C)(C)C)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
PGR P06401 1/20 0.44
RORA P35398 1/20 0.44
RORC P51449 1/20 0.44
RORB Q92753 1/20 0.44
HTR1D P28221 1/20 0.42
DNMT1 P26358 3/20 0.41
HRH3 Q9Y5N1 1/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
PTGES2 Q9H7Z7 2/20 0.38
HPGD P15428 1/20 0.38
PTGES O14684 1/20 0.38
ATM Q13315 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
HCRTR1 O43613 1/20 0.37
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
SLC5A2 P31639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30849653 1.00 MAPT (0.44) MAPTPGRRORARORCRORB
SCHEMBL26500398 0.84 PGR (0.43) MAPTPGRRORARORCRORB
SCHEMBL26144555 0.77 PGR (0.53) MAPTPGRRORARORCRORB
SCHEMBL30849654 0.77 PGR (0.53) MAPTPGRRORARORCRORB
SCHEMBL27798318 0.76 PGR (0.49) MAPTPGRRORARORCRORB
SCHEMBL4026771 0.76 HTR1D (0.41) MAPTPGRRORARORCRORB
SCHEMBL15081186 0.74 PTGES2 (0.46) MAPTPGRRORARORCRORB
SCHEMBL11825251 0.74 MAPT (0.47) MAPTALDH1A1GAAATML3MBTL1
SCHEMBL17417873 0.74 MAPT (0.50) MAPTALDH1A1GAAHPGDATM
SCHEMBL8158727 0.74 MAPT (0.40) MAPTALDH1A1PKMATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609258-B2 Light emitting devices and compositions NITTO DENKO CORPORATION (JP) 2013-12-17 US disclosed
US-20120305895-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2012-12-06 US disclosed
US-20120305895-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2012-12-06 US disclosed
US-20120305895-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2012-12-06 US disclosed
US-20090066234-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2009-03-12 US disclosed
US-20090066234-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2009-03-12 US disclosed
WO-2009006550-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2009-01-08 WO disclosed
WO-2009006550-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS NITTO DENKO CORPORATION (JP) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090066234-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS MAP1LC3A, MAP1LC3C, CRY1 MAPT 53/4885PGR 2698/4885RORA 409/4885
US-20120305895-A1 LIGHT EMITTING DEVICES AND COMPOSITIONS ILK, CRY1, IK MAPT 251/4885PGR 2213/4885RORA 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.